Yea Christopher

CHIEF DEVELOPMENT OFFICER

Yea Christopher has filed 10 SEC Form 4 filings (20 transaction rows) across 1 company, with disclosures dating back to 2025. 10 of those filings fall inside the rolling window. Most recent filing: Jun 11, 2026.

On the most recent filing, Yea Christopher is listed as CHIEF DEVELOPMENT OFFICER at KalVista Pharmaceuticals, Inc. Inside the rolling window, Yea Christopher reported no open-market purchases and 8 open-market sales totaling $1.2M in KALV. The largest disclosed transaction in the window is a sale of 33,800 KALV shares on May 27, 2026, worth $905K.

Companies traded

Other insiders at KALV

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.2M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
KALVSale$905KMay 29SEC ↗
KALVSale$53KMay 27SEC ↗
KALVSale$63KMay 26SEC ↗
KALVSale$30KMay 19SEC ↗
KALVSale$68KFeb 24SEC ↗
KALVSale$17KFeb 19SEC ↗
KALVSale$58KNov 26SEC ↗
KALVSale$39KNov 19SEC ↗

Frequently asked questions

How many SEC Form 4 filings has Yea Christopher made?

Yea Christopher has filed 10 SEC Form 4 filings (20 transaction rows) across 1 company since 2025.

Which companies does Yea Christopher trade?

Yea Christopher has filed SEC Form 4 disclosures for 1 company, including KALV.

When was Yea Christopher's most recent SEC Form 4 filing?

Yea Christopher's most recent SEC Form 4 filing on Tracefour is dated Jun 11, 2026.

What is Yea Christopher's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Yea Christopher is listed as CHIEF DEVELOPMENT OFFICER.

What is Yea Christopher's total buy and sell value in the current window?

Inside the rolling retention window, Yea Christopher bought $0 and sold $1.2M based on SEC Form 4 filings.

What was Yea Christopher's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 33,800 KALV shares on 2026-05-27, worth $905K, per SEC Form 4 filings.